Subscribe to Newsletter
Subspecialties Glaucoma, Business and Innovation

MINIject: A MIGS Breakthrough

sponsored by iSTAR Medical

MIGS has been a game changer in controlling glaucoma patients’ intraocular pressure (IOP). iSTAR Medical’s new MINIject® implant has a unique silicone structure that minimizes scarring and maintains the implant’s performance over the long term. This allows for sustained control of IOP and is particularly suited for patients with mild to moderate glaucoma.

Here, Michel Vanbrabant, CEO of iSTAR Medical, and Karsten Klabe, ophthalmic surgeon at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, present the key features and unique aspects of MINIject from the floor of ESCRS 2022.

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Case Study
Finding Ocular Surface Inflammation

| Contributed by Quidel

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Most Popular
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: